MEDICO35.00

Medico Remedies Limited

· Pharma & Health
₹ CrorePeersMEDICAMEQHALEOSLABSAAREYDRUGSNECLIFEALBERTDAVDVALIANTLABNATCAPSUQZIMLABMcap ₹0.1 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation2.93.03.1
+ Interest Income0.00.0-0.1
+ Fair Value (Gains) / Losses0.00.0-0.0
+ Other Non-cash Items0.6-0.60.0
+ Other — Cash Effects are Investing / Financing0.10.10.0
+ Other Reconciling Items0.00.00.2
Changes in Working Capital
+ Inventories3.4-10.4-3.3
+ Trade Receivables — Current-13.6-7.00.0
+ Trade Receivables — Non-current0.00.0-25.1
+ Other Financial Assets — Current0.30.00.0
+ Other Financial Assets — Non-current0.0-0.0-0.0
+ Other Current Assets0.3-4.0-0.0
+ Other Non-current Assets0.00.0-2.8
+ Trade Payables — Current0.53.214.6
+ Other Financial Liabilities — Current0.03.80.0
+ Other Current Liabilities-0.07.11.8
+ Other Non-current Liabilities0.00.04.7
+ Provisions — Current-0.10.0-0.1
Cash from Operating Activities
Profit Before Tax (per I/S)11.313.518.119.0
+ Total Adjustments (incl. Working Capital)-5.6-4.7-7.1
Cash from Operations (pre-tax)5.78.810.9
+ Interest Received — Operating-0.1-0.10.0
+ Income Taxes Paid3.23.85.1
Cash from Operating Activities2.44.95.9
Cash from Investing Activities
+ Disp of Fixed Assets0.00.00.1
+ Acq of Investment Property0.10.10.4
+ Loans & Advances Repaid0.00.00.0
+ Interest Received — Investing0.10.10.1
+ Other Inflows / (Outflows) — Investing-2.7-3.5-4.3
Cash from Investing Activities-2.7-3.5-4.5
Cash from Financing Activities
+ Payment of Lease Liabilities0.50.50.6
Cash from Financing Activities-0.5-0.5-0.6
Net Changes in Cash (pre-FX)-0.70.90.8
Net Changes in Cash-0.70.90.8
Closing Cash0.2
Reference Items
EBITDA12.915.017.017.5
EBITDA Margin %8.919.948.257.37
Free Cash Flow (CFO − Capex)2.44.95.95.9
Free Cash Flow to Equity11.510.0
Free Cash Flow per Basic Share864.881,735.502,083.902,083.90
Price to Free Cash Flow0.02
Cash Flow to Net Income0.290.480.45
Cash Paid for Taxes3.23.85.1
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.